| Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL G Tzoneva, A Perez-Garcia, Z Carpenter, H Khiabanian, V Tosello, ... Nature medicine 19 (3), 368-371, 2013 | 379 | 2013 |
| Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia K Oshima, H Khiabanian, AC da Silva-Almeida, G Tzoneva, F Abate, ... Proceedings of the National Academy of Sciences 113 (40), 11306-11311, 2016 | 193 | 2016 |
| Negative feedback–defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL B Li, H Li, Y Bai, R Kirschner-Schwabe, JJ Yang, Y Chen, G Lu, ... Nature medicine 21 (6), 563-571, 2015 | 172 | 2015 |
| Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia G Tzoneva, CL Dieck, K Oshima, A Ambesi-Impiombato, ... Nature 553 (7689), 511-514, 2018 | 109 | 2018 |
| Recent advances on NOTCH signaling in T-ALL G Tzoneva, AA Ferrando Notch Regulation of the Immune System, 163-182, 2012 | 85 | 2012 |
| Structure and mechanisms of NT5C2 mutations driving thiopurine resistance in relapsed lymphoblastic leukemia CL Dieck, G Tzoneva, F Forouhar, Z Carpenter, A Ambesi-Impiombato, ... Cancer cell 34 (1), 136-147. e6, 2018 | 47 | 2018 |
| Genetic and functional evidence links a missense variant in B4GALT1 to lower LDL and fibrinogen ME Montasser, CV Van Hout, L Miloscio, AD Howard, A Rosenberg, ... Science 374 (6572), 1221-1227, 2021 | 12 | 2021 |
| Deregulated LAP2α expression in cervical cancer associates with aberrant E2F and p53 activities MC Ward, PJ van der Watt, G Tzoneva, VD Leaner IUBMB life 63 (11), 1018-1026, 2011 | 12 | 2011 |
| Genetic and functional evidence relates a missense variant in B4GALT1 to lower LDL-C and fibrinogen ME Montasser, CV Van Hout, R McFarland, A Rosenberg, M Callaway, ... bioRxiv, 721704, 2019 | 5 | 2019 |
| Abstract PR02: Mechanisms of NT5C2 activating mutations driving thiopurine resistance in relapsed lymphoblastic leukemia CL Dieck, G Tzoneva, F Forouhar, Z Carpenter, M Sanchez-Martin, ... Clinical Cancer Research 23 (24 Supplement), PR02-PR02, 2017 | | 2017 |
| Mechanisms of NT5C2 mutations Driving Thiopurine Resistance in Acute Lymphoblastic Leukemia C Dieck, G Tzoneva, F Forouhar, Z Carpenter, A Ambesi-Impiombato, ... Blood 130 (Supplement 1), 715-715, 2017 | | 2017 |
| Clonal Evolution Mechanisms and Collateral Sensitivity to Impdh Inhibitor Therapy in Relapsed Lymphoblastic Leukemia C Dieck, G Tzoneva, K Oshima, A Ambesi-Impiombato, M Sanchez-Martin, ... Blood 130 (Supplement 1), 2602-2602, 2017 | | 2017 |
| Mechanisms of NT5C2 activating mutations driving thiopurine resistance in relapsed lymphoblastic leukemia. CL Dieck, G Tzoneva, F Forouhar, Z Carpenter, M Sanchez-Martin, ... CLINICAL CANCER RESEARCH 23 (24), 27-27, 2017 | | 2017 |
| The role of cytosolic 5'-nucleotidase II (NT5C2) in drug resistance and relapse of acute lymphoblastic leukemia GV Tzoneva Columbia University, 2016 | | 2016 |
Zachary CarpenterColumbia UniversityVerified email at Columbia.edu
